Amir Hossein Gougol

Amir Gougol is a gastroenterologist and transplant hepatologist currently practicing as clinical assistant professor at Stanford University. Amir has received his medical education at Tehran University in Iran. He pursued his internal medicine training and a gastroenterology fellowship at the University of Pittsburgh, Pennsylvania. He was also trained in Transplant Hepatology at the University of California, San Francisco (UCSF). He has a particular clinical interest in implementation of point-of-care ultrasound (POCUS) in hepatology care.

Julius M Wilder

Julius Wilder, MD, PhD, is an Associate Professor of Medicine at Duke University School of Medicine. He has an appointment with the Duke Clinical Research Institute and a secondary appointment with the Department of Sociology at Duke University. Dr. Wilder graduated with honors as a Meyerhoff Scholar from the University of Maryland Baltimore County before matriculating to Duke University School of Medicine where he received the first MD, PhD in Medical Sociology in the history of Duke University.

Teresa L Bordeaux

Teresa Bordeaux is the Chief Operating Officer/Chief Financial Officer for the National Blood Clot Alliance. Prior to joining the staff of NBCA in 2023, Teresa previously served in the volunteer roles of Board Chair, Treasurer and Board Member. Teresa is a Certified Public Accountant and worked for 17 years at the Association of International Certified Professional Accountants. She began her career in public accounting and worked in State and Local government in North Carolina before joining AICPA. 

Christina N Awad

Dr. Christina Awad is a gastroenterologist, Medical Director of Hepatology, and Faculty Director for AI and Innovation at UT Health San Antonio. Her clinical, educational, and research efforts focus on advancing artificial intelligence (AI) literacy among healthcare professionals, with the goal of equipping clinicians to safely, effectively, and responsibly integrate AI into clinical practice amid rapidly evolving technologies.

Marina Serper

Dr. Serper is Associate Professor of Medicine at the University of Pennsylvania. She is a transplant hepatologist with expertise in epidemiology, health services research, patient-oriented research and digital health. Her research works studying clinical outcomes in cirrhosis and designing interventions to improve health outcomes of patients with chronic advanced liver disease, alcohol-associated liver disease, and liver transplantation.

David Lee

David D. Lee, MD is Associate Professor of Surgery at Harvard Medical School and Surgical Director of Liver Transplantation and Quality Director at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. He also serves as Associate Editor of Liver Transplantation.

Neil Mehta

I am a Transplant Hepatologist and Clinical Professor of Medicine at UCSF. I am the Director of our Liver Cancer Multidisciplinary Program as well as the Medical Director of our Live Donor Liver Transplantation program. My research focus is primarily on selection criteria and liver transplant outcomes for patients with HCC including with respect to down-staging, incorporation of biomarkers, and improving transplant access.

Timucin Taner

Dr. Taner is a Professor of Surgery and Consultant in Immunology at Mayo Clinic, Rochester. He is the Chair of the Division of Transplantation Surgery at the same institution. His clinical practice involves liver transplantation, living donor hepatectomies and nephrectomies. His research focuses on liver transplant immunobiology, investigating interactions between liver allografts and host immune responses. He is the current co-Editor-in-Chief of Liver Transplantation.

Andres Cardenas

Dr. Cárdenas is a Staff Member and Consultant of the Institute of Digestive Diseases and Metabolism at Hospital Clinic and Accredited Professor of Medicine (Catalan Agency for Quality Assessment) with the University of Barcelona. He pursued his Residency and Fellowship in Internal Medicine, Gastroenterology, Hepatology at Boston University and Harvard Medical School at Beth Israel Deaconess Medical Center in Boston. Dr. Cardenas is Board Certified in Internal Medicine, Gastroenterology and Hepatology by the American Board of Internal Medicine.

Subscribe to